AI drug discovery

March 8, 2021

Atomwise wins “Best use of AI in Health and Medicine” in 5th Annual AI Awards

In The News

Read Article

January 12, 2021

What DeepMind’s leap means for structure-based drug developers

In The News

Read Article

September 8, 2020

GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise

FeaturedPress Release

The partnership will develop new drug programs that advance GC Pharma’s global leadership in hemophilia and additional disease areas SAN FRANCISCO & YONGIN, South Korea–(BUSINESS WIRE)–Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced today a partnership with GC Pharma (KRX: 006280), a South Korean biopharmaceutical company formerly known as Green Cross […]

Read Article

January 7, 2020

Bayer Exercises Right to Enter Into Follow-On Research and Collaboration Option Agreement With Atomwise

Press Release

Companies to continue crop protection development programs January 07, 2020 08:30 AM Eastern Standard Time MONHEIM, Germany & SAN FRANCISCO–(BUSINESS WIRE)–Bayer and Atomwise, the leader in artificial intelligence (AI) for drug discovery, today announced the companies will continue the development of two crop protection programs. Farmers across the world are facing an increase in weed, insect and […]

Read Article